Loading
Latest filing published 16 Dec 2025 for Traws Pharma, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mary Teresa Shoemaker is a declared insider of Traws Pharma, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 25 November 2020 to 12 December 2025, the count stands at 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €19k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant.
The latest filing, published on 16 December 2025, reports a share grant in Traws Pharma, Inc. The latest purchase dates back some time: it was published 2,074 days ago, on 17 February 2021. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations